Tisotumab Vedotin is a tissue factor-directed antibody-drug conjugate (ADC) containing a tissue factor-specific fully human monoclonal antibody (TF-011) conjugated to monomethylmethane auristatin E (MMAE), which can be used in studies related to cervical cancer.
Purity:
>99.0%
CAS Number:
[1418731-10-8]
* VAT and and shipping costs not included. Errors and price changes excepted